Literature DB >> 16621658

Responsiveness of impairments and disabilities in Parkinson's disease.

M Visser1, J Marinus, A M Stiggelbout, J J van Hilten.   

Abstract

The objective of this study is to evaluate the responsiveness of items of the Activities of Daily Living (ADL) and Motor section of the Unified Parkinson's Disease Rating Scale (UPDRS) in patients with Parkinson's Disease (PD). A standardized Response Mean (SRM) per item was calculated using data of four trials (n=376) that randomised patients with early PD to dopamine agonist (DA) monotherapy or placebo. In the ADL section, the SRMs ranged from -0.04 (no effect) to -0.50 (moderate effect). Hand functions were the most responsive ADL items with 'handwriting' showing the largest response. Self-assessed symptoms were the least responsive. In the Motor section, SRMs ranged from -0.09 to -0.60 with bradykinesia items showing the largest response, especially the item 'finger taps'. The tremor items showed the smallest response, however, rest tremor arms was much more responsive than rest tremor of the head and legs or postural tremor. SRMs in the placebo group ranged from 0.08 to -0.21 in the ADL section and from 0.03 to -0.35 in the Motor section. ADL and motor items have comparable and mostly small effect sizes. The most responsive items are in the ADL section hand functions and in the Motor section bradykinesia items. A more responsive ADL section would omit the self-assessed symptoms and the Motor section would retain only rest tremor arms of the tremor items.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621658     DOI: 10.1016/j.parkreldis.2006.01.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed.

Authors:  Avner Shahar; Kushang V Patel; Richard D Semba; Stefania Bandinelli; Danit R Shahar; Louigi Ferrucci; Jack M Guralnik
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

2.  Use of sensitive devices to assess the effect of medication on attentional demands of precision and power grips in individuals with Parkinson disease.

Authors:  Sujata D Pradhan; Reinhold Scherer; Yoky Matsuoka; Valerie E Kelly
Journal:  Med Biol Eng Comput       Date:  2011-07-12       Impact factor: 2.602

3.  Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.

Authors:  Nir Giladi; Anthony P Nicholas; Mahnaz Asgharnejad; Elisabeth Dohin; Franz Woltering; Lars Bauer; Werner Poewe
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

4.  Effects of dopamine D1 and D2 receptor antagonists on laryngeal neurophysiology in the rat.

Authors:  Xin Feng; Victor M Henriquez; Judith R Walters; Christy L Ludlow
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

5.  Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely.

Authors:  Amir Abdolahi; Nicholas Scoglio; Annie Killoran; E Ray Dorsey; Kevin M Biglan
Journal:  Parkinsonism Relat Disord       Date:  2012-10-25       Impact factor: 4.891

6.  Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.

Authors:  Laurie K Mischley; Richard C Lau; Noel S Weiss
Journal:  NPJ Parkinsons Dis       Date:  2017-06-16

7.  Functional Connectivity Changes of Key Regions for Motor Initiation in Parkinson's Disease.

Authors:  Lukas Hensel; Felix Hoffstaedter; Julian Caspers; Jochen Michely; Christian Mathys; Julia Heller; Claudia R Eickhoff; Kathrin Reetz; Martin Südmeyer; Gereon R Fink; Alfons Schnitzler; Christian Grefkes; Simon B Eickhoff
Journal:  Cereb Cortex       Date:  2019-01-01       Impact factor: 5.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.